Dicot Pharma AB (STO:DICOT)

Dicot Pharma AB Statistics

Total Valuation

Dicot Pharma AB has a market cap or net worth of SEK 590.75 million. The enterprise value is 534.55 million.

Market Cap	590.75M
Enterprise Value	534.55M

Important Dates

The last earnings date was Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Dicot Pharma AB has 2.01 billion shares outstanding.

Current Share Class	2.01B
Shares Outstanding	2.01B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	11.30%
Owned by Institutions (%)	11.09%
Float	1.70B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	10.10
P/TBV Ratio	10.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.41
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.72

Current Ratio	5.72
Quick Ratio	4.97
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12,353.67

Financial Efficiency

Return on equity (ROE) is -98.21% and return on invested capital (ROIC) is -63.07%.

Return on Equity (ROE)	-98.21%
Return on Assets (ROA)	-53.43%
Return on Invested Capital (ROIC)	-63.07%
Return on Capital Employed (ROCE)	-126.70%
Weighted Average Cost of Capital (WACC)	9.23%
Revenue Per Employee	n/a
Profits Per Employee	-18.03M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.85% in the last 52 weeks. The beta is 0.91, so Dicot Pharma AB's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	-17.85%
50-Day Moving Average	0.36
200-Day Moving Average	0.52
Relative Strength Index (RSI)	31.63
Average Volume (20 Days)	9,461,102

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-74.12M
Pretax Income	-72.14M
Net Income	-72.14M
EBITDA	n/a
EBIT	-74.12M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 56.20 million in cash and n/a in debt, with a net cash position of 56.20 million or 0.03 per share.

Cash & Cash Equivalents	56.20M
Total Debt	n/a
Net Cash	56.20M
Net Cash Per Share	0.03
Equity (Book Value)	58.50M
Book Value Per Share	n/a
Working Capital	58.50M

Cash Flow

Operating Cash Flow	-78.45M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Dicot Pharma AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-12.21%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a